GENE Shares Outstanding History Table | ||||||
Also see: GENE Market Cap History GENE YTD Return |
GENE Shares Outstanding History Table | ||||||
Also see: GENE Market Cap History GENE YTD Return |
GENE Shares Outstanding History Chart | |||||||
-76.27% CAGR ![]() Mouse over chart for data details
|
GENE Stock Price Chart |
About Genetic Technologies Ltd. |
Genetic Technologies is a molecular diagnostics company that provides predictive testing and assessment tools to help physicians manage women's health. Co.'s key product, BREVAGenplus, was a clinically validated risk assessment test for non-hereditary breast cancer. Co. has launched the first generation BREVAGen test across the U.S. via its U.S. subsidiary Phenogen Sciences Inc. Co. has developed two new cancer risk assessment tests branded as GeneType for Colorectal Cancer and GeneType for Breast Cancer. Co. also develops other risk assessment tests across a range of diseases, including cardiovascular disease, type 2 diabetes, prostate cancer and melanoma. We show 2 historical shares outstanding datapoints in our coverage of GENE's shares outstanding history. Understanding the changing numbers of GENE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GENE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GENE by allowing them to research GENE shares outstanding history as well as any other stock in our coverage universe. |
GENE Current Stock Quote |
![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() |
Video: Shares Outstanding Importance | |
|
GENE Share Performance |
Shares Outstanding Peers |
Genetic Technologies. (GENE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GERN Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.